For Practitioners

RadFlix is a unique, game-changing system that allows patients to watch their favorite movies during radiation.

  • Watching videos during medical procedures can decrease anxiety in children.  This is a proven approach shown effective in MRI and Radiation treatments.
  • Patient selects movie options during consultation – Disney+ and NetFlix
  • System setup takes 1 minute and take down is even shorter
  • Controls are outside of vault, enabling therapists to easily control media
  • Movie pauses at end of each radiation session and resumes from same position during next session
  • Kids feel like they have some control during treatment

Radically Quick Facts

  • RadFlix has been rigorously tested at University of Colorado to make it robust, reliable, and functional
  • Radiation therapists can set up the procedure in one minute and take it down in 20 seconds.
  • In 2022, RadFlix established a partnership with the highly trusted and impactful Morgan Adams Foundation for funding and fundraising.
  • Today, RadFlix is offered to every pediatric patient at UCHealth and we have treated over 150 children with phenomenal feedback from patients and families.

About the RadFlix design

  • Allows any treatment approach
  • Compatible with all radiation techniques and body sites
  • Seamless integration into clinical workflow
  • Proton beam compatible
  • Field tested and robust
  • Patented design

About The Morgan Adams Foundation

The Morgan Adams Foundation (MAF) funds kids’ cancer research.  MAF raises awareness of, and educates communities about, the need for pediatric and young adult specific cancer treatments.

Working with leading researchers and physicians, MAF funds new and innovative ideas that will improve cancer treatment effectiveness, overall outcomes, survival rates and quality of life while minimizing the devastating side effects current treatments have on our children.

MAF’s particular interest is to provide seed and bridge grants for viable investigations not yet ripe enough for total funding by larger organizations. Additionally, they are able to partially fund translational studies, experimental therapeutics studies, and/or Phase I and II clinical trials on a case-by-case basis.

MAF increasingly seeks projects that are highly collaborative and/or multi-institutional in nature. Their hope is that they can facilitate, through strategic funding, more rapid clinical trial development to get the best possible treatment options into circulation as expediently as possible.

Through careful consideration and placement of our funding, MAF encourages and supports research intended to improve treatment effectiveness, treatment outcomes, and the quality of life for children battling cancer.